Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 50037812
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193999(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-((S)-1-phenyle...)
Affinity DataIC50: 4nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194011(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N4,N4-dimethyl-N...)
Affinity DataIC50: 7nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193989(N-((S)-1-(4-fluorophenyl)ethyl)-2-(3H-imidazo[4,5-...)
Affinity DataIC50: 8nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193995(CP-690550 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrro...)
Affinity DataIC50: 11nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194009(6-(3,4-dimethoxyphenyl)-2-(3H-imidazo[4,5-c]pyridi...)
Affinity DataIC50: 12nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193995(CP-690550 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrro...)
Affinity DataIC50: 13nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193990(6-(furan-3-yl)-2-(3H-imidazo[4,5-c]pyridin-3-yl)-N...)
Affinity DataIC50: 16nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194015(3-(4-(2-chlorophenoxy)-6-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50: 17nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193994(4-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-phen...)
Affinity DataIC50: 18nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194011(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N4,N4-dimethyl-N...)
Affinity DataIC50: 19nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193991(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-(4-methylpiper...)
Affinity DataIC50: 19nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194010(6-(4-(dimethylamino)phenyl)-2-(3H-imidazo[4,5-c]py...)
Affinity DataIC50: 20nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193999(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-((S)-1-phenyle...)
Affinity DataIC50: 21nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194015(3-(4-(2-chlorophenoxy)-6-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50: 27nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194005(N-((S)-1-(4-fluorophenyl)ethyl)-6-(furan-3-yl)-2-(...)
Affinity DataIC50: 28nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194008(3-(4-(furan-3-yl)-6-((S)-1-phenylethylamino)pyrimi...)
Affinity DataIC50: 29nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194008(3-(4-(furan-3-yl)-6-((S)-1-phenylethylamino)pyrimi...)
Affinity DataIC50: 31nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50132420(CHEMBL2397013 | CHEMBL323994 | 3-((1H-pyrrol-2-yl)...)
Affinity DataIC50: 38nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193994(4-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-phen...)
Affinity DataIC50: 42nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193993(3-(4-((S)-1-methoxypropan-2-ylamino)pyrimidin-2-yl...)
Affinity DataIC50: 45nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194009(6-(3,4-dimethoxyphenyl)-2-(3H-imidazo[4,5-c]pyridi...)
Affinity DataIC50: 49nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193987(4-(3H-imidazo[4,5-c]pyridin-3-yl)-N-((R)-1-phenyle...)
Affinity DataIC50: 49nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193996(2-(1H-imidazo[4,5-c]pyridin-1-yl)-N-((S)-1-phenyle...)
Affinity DataIC50: 51nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193997(CHEMBL220484 | CHEMBL557844 | 6-(furan-3-yl)-2-(3H...)
Affinity DataIC50: 51nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194004(N-((S)-1-(4-chlorophenyl)ethyl)-2-(3H-imidazo[4,5-...)
Affinity DataIC50: 51nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194000(3-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-phen...)
Affinity DataIC50: 56nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194013((R)-1-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-...)
Affinity DataIC50: 59nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193990(6-(furan-3-yl)-2-(3H-imidazo[4,5-c]pyridin-3-yl)-N...)
Affinity DataIC50: 60nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193991(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-(4-methylpiper...)
Affinity DataIC50: 61nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194010(6-(4-(dimethylamino)phenyl)-2-(3H-imidazo[4,5-c]py...)
Affinity DataIC50: 62nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194007(3-(4-(2,6-difluorophenoxy)-6-(4-methylpiperazin-1-...)
Affinity DataIC50: 68nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194014(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-(1-methyl-1H-p...)
Affinity DataIC50: 77nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194005(N-((S)-1-(4-fluorophenyl)ethyl)-6-(furan-3-yl)-2-(...)
Affinity DataIC50: 83nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193989(N-((S)-1-(4-fluorophenyl)ethyl)-2-(3H-imidazo[4,5-...)
Affinity DataIC50: 92nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194002(N-(2-chlorophenyl)-2-(3H-imidazo[4,5-c]pyridin-3-y...)
Affinity DataIC50: 113nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194007(3-(4-(2,6-difluorophenoxy)-6-(4-methylpiperazin-1-...)
Affinity DataIC50: 120nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193993(3-(4-((S)-1-methoxypropan-2-ylamino)pyrimidin-2-yl...)
Affinity DataIC50: 124nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194002(N-(2-chlorophenyl)-2-(3H-imidazo[4,5-c]pyridin-3-y...)
Affinity DataIC50: 131nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193997(CHEMBL220484 | CHEMBL557844 | 6-(furan-3-yl)-2-(3H...)
Affinity DataIC50: 141nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193987(4-(3H-imidazo[4,5-c]pyridin-3-yl)-N-((R)-1-phenyle...)
Affinity DataIC50: 145nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194003(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-methyl-N-((S)-...)
Affinity DataIC50: 153nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193997(CHEMBL220484 | CHEMBL557844 | 6-(furan-3-yl)-2-(3H...)
Affinity DataIC50: 165nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194006(6-(3-(dimethylamino)phenyl)-2-(3H-imidazo[4,5-c]py...)
Affinity DataIC50: 167nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194000(3-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-phen...)
Affinity DataIC50: 167nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194013((R)-1-(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-((S)-1-...)
Affinity DataIC50: 180nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194014(2-(3H-imidazo[4,5-c]pyridin-3-yl)-6-(1-methyl-1H-p...)
Affinity DataIC50: 245nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193997(CHEMBL220484 | CHEMBL557844 | 6-(furan-3-yl)-2-(3H...)
Affinity DataIC50: 446nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50194006(6-(3-(dimethylamino)phenyl)-2-(3H-imidazo[4,5-c]py...)
Affinity DataIC50: 470nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50132420(CHEMBL2397013 | CHEMBL323994 | 3-((1H-pyrrol-2-yl)...)
Affinity DataIC50: 600nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193996(2-(1H-imidazo[4,5-c]pyridin-1-yl)-N-((S)-1-phenyle...)
Affinity DataIC50: 700nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: